The FDA is proposing ending use of a popular nasal decongestant, phenylephrine, in oral form. The FDA’s proposal is based on effectiveness concerns, not safety concerns. Phenylephrine is an active ...

The FDA announced on Thursday a proposed order to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) nasal decongestion drugs after a comprehensive review of the available ...

Please provide your email address to receive an email when new articles are posted on . An FDA review found that oral phenylephrine is not effective in treating nasal congestion. The proposal is based ...

WASHINGTON -- The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular over-the-counter decongestants - from the market, citing ...

A pharmaceutical ingredient that’s been a key component in nasal decongestants for decades is having its efficacy called into question, and the FDA is now weighing whether to change the compound’s ...

WASHINGTON — Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter medicines, ...

Rite Aid will continue to keep products with phenylephrine on their shelves, at least for now, a spokesperson tells ABC. "Rite Aid follows guidance from regulatory agencies, including the FDA, and is ...